Refine
Year of publication
Document Type
- Preprint (582)
- Article (390)
- Conference Proceeding (3)
- Doctoral Thesis (1)
Has Fulltext
- yes (976)
Is part of the Bibliography
- no (976)
Keywords
- Heavy Ion Experiments (18)
- Hadron-Hadron scattering (experiments) (11)
- BESIII (8)
- Heavy-ion collision (6)
- LHC (6)
- Hadron-Hadron Scattering (4)
- Kollisionen schwerer Ionen (4)
- Quark-Gluon Plasma (4)
- heavy ion collisions (4)
- ALICE experiment (3)
- Branching fractions (3)
- Hadronic decays (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- Quark Gluon Plasma (3)
- Atmospheric science (2)
- Beauty production (2)
- Charm physics (2)
- Charmonium (2)
- Climate change (2)
- Cross section (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Jets (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- QGP (2)
- Quark-Gluon-Plasma (2)
- Single electrons (2)
- UrQMD Modell (2)
- pp collisions (2)
- quark-gluon-plasma (2)
- ADHD (1)
- ALICE (1)
- ALICE detector (1)
- Absolute branching fraction (1)
- Accelerators & Beams (1)
- Accelerators & storage rings (1)
- Acute coronary syndrome (1)
- Angular distribution (1)
- Annihilation (1)
- Anti-nuclei (1)
- Atmospheric chemistry (1)
- Atomic & molecular beams (1)
- Atomic, Molecular & Optical (1)
- Atrial fibrillation (1)
- BNC2 (1)
- BRCA1 (1)
- BRCA2 (1)
- Beam loss (1)
- Bhabha (1)
- Big Five (1)
- Bleeding (1)
- Body mass index (1)
- Branching fraction (1)
- Breast cancer (1)
- CDH13 (1)
- COVID-19 (1)
- Cancer risk factors (1)
- Cancer treatment (1)
- Cardiac troponin (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge-transfer collisions (1)
- Chemical composition (1)
- Chemotherapy (1)
- Circular accelerators (1)
- Collective Flow (1)
- Colorectal cancer (1)
- Cross section measurements (1)
- Cytomegalie (1)
- Cytomegalovirus Infection (1)
- D meson (1)
- D0 and D+ mesons (1)
- Dalitz decay (1)
- Demolition emissions (1)
- D⁰ meson (1)
- Electromagnetic amplitude (1)
- Electromagnetic form factor (1)
- Electron-pion identification (1)
- Electronic transitions (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Energie (1)
- Enzyme-linked Immunosorbent Assay (1)
- Exosomes (1)
- Fibre/foam sandwich radiator (1)
- HER2-positive (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hadronic cross section (1)
- Hadrons (1)
- Head and neck Cancer (1)
- Heavy Ion Experiment (1)
- Heavy Quark Production (1)
- Heavy flavor production (1)
- Heavy ion storage ring (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Hereditary breast and ovarian cancer (1)
- Human behaviour (1)
- INR (1)
- Initial state radiation (1)
- International normalized ratio (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- LUT (1)
- Lesions (1)
- Low & intermediate-energy accelerators (1)
- Lymphadenopathy (1)
- Lymphomas (1)
- MicroRNAs (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Molecular neuroscience (1)
- Monte Carlo (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multivariate analysis (1)
- Muon anomaly (1)
- Myocardial infarction (1)
- NMR spectroscopy (1)
- Neoadjuvant therapy (1)
- Neural network (1)
- Obesity (1)
- Oposterior urethral valve (1)
- Orbital electron capture (1)
- PM10 (1)
- Particle Correlations and Fluctuations (1)
- Pathological complete response (1)
- Personalized medicine (1)
- Phase (1)
- Photon counting (1)
- Pion form factor (1)
- Point-of-care testing (1)
- Polymerase Chain Reaction (1)
- Polymerasekettenreaktion (1)
- Predictive markers (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Proton–proton (1)
- Psychiatric disorders (1)
- QCD (1)
- Quark Production (1)
- Quark gluon plasma (1)
- R value (1)
- RNAi (1)
- Rapidity Range (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Resolution Parameter (1)
- SARS-CoV-2 (1)
- SPS (1)
- Salivary gland diseases (1)
- Sensitivity and Specificity (1)
- Sensitivität und Spezifität (1)
- Serodiagnose (1)
- Serodiagnosis (1)
- Single particle decay spectroscopy (1)
- Size distribution (1)
- Strong amplitude (1)
- Structured reporting (1)
- Systematic Uncertainty (1)
- TR (1)
- Time Projection Chamber (1)
- Total colonoscopy (1)
- Toxicity (1)
- Tracking (1)
- Transition radiation detector (1)
- Transplantation/Immunologie (1)
- Transplantation/immunology (1)
- Trigger (1)
- Triple negative (1)
- Triple quarkonia (1)
- Triple-negative breast cancer (1)
- Two body weak decay (1)
- URQMD (1)
- Ultra-relativistic Quantum Molecular Dynamics model (1)
- Ultrafine particles (1)
- Ultrarelativistic Quantum Molecular Dynamics (1)
- Ultrarelativistic Quantum Molecular Model (1)
- Ultrarelativistisches Quant Molekulares Modell (1)
- Ultrasonography (1)
- UrQMD model (1)
- Urban aerosol (1)
- Vector Boson Production (1)
- Viral Matrix Proteins (1)
- Virale Matrixproteine (1)
- W-exchange (1)
- Xenon-based gas mixture (1)
- Y (4260) (1)
- accessory proteins (1)
- adeno-associated virus (1)
- agreeableness (1)
- amino acid PET (1)
- artificial intelligence (1)
- basonuclin 2 (1)
- branching fractions (1)
- cell-free protein synthesis (1)
- charmed baryon (1)
- cloacae (1)
- dE/dx (1)
- decay (1)
- decays (1)
- diphoton (1)
- distal pronephric outlet obstruction (1)
- e+e− annihilation (1)
- energy (1)
- executive functions (1)
- expression studies (1)
- functional genetics (1)
- glioma (1)
- hadron hadron Kollision (1)
- hadron hadron collision (1)
- heavy ion experiments (1)
- heavy ions (1)
- intrinsically disordered region (1)
- lower urinary tract obstruction (1)
- luminosity (1)
- neurodevelopment (1)
- neurodevelopmental disorders (1)
- nonstructural proteins (1)
- pronephric development (1)
- quark gluon plasma (1)
- relativistic (1)
- relativistische (1)
- schwere Ione (1)
- spectra (1)
- structural proteins (1)
- treatment-related changes (1)
- tumor progression (1)
- viral gene transfer (1)
- working memory (1)
- x-ray techniques (1)
- zebrafish (1)
- Λc⁺ (1)
- Σ hyperon (1)
Institute
- Physik (950)
- Frankfurt Institute for Advanced Studies (FIAS) (810)
- Informatik (775)
- Medizin (16)
- Geowissenschaften (4)
- Geowissenschaften / Geographie (3)
- Hochschulrechenzentrum (3)
- Informatik und Mathematik (3)
- ELEMENTS (2)
- Biochemie und Chemie (1)
Congenital lower urinary-tract obstruction (LUTO) is caused by anatomical blockage of the bladder outflow tract or by functional impairment of urinary voiding. About three out of 10,000 pregnancies are affected. Although several monogenic causes of functional obstruction have been defined, it is unknown whether congenital LUTO caused by anatomical blockage has a monogenic cause. Exome sequencing in a family with four affected individuals with anatomical blockage of the urethra identified a rare nonsense variant (c.2557C>T [p.Arg853∗]) in BNC2, encoding basonuclin 2, tracking with LUTO over three generations. Re-sequencing BNC2 in 697 individuals with LUTO revealed three further independent missense variants in three unrelated families. In human and mouse embryogenesis, basonuclin 2 was detected in lower urinary-tract rudiments. In zebrafish embryos, bnc2 was expressed in the pronephric duct and cloaca, analogs of the mammalian lower urinary tract. Experimental knockdown of Bnc2 in zebrafish caused pronephric-outlet obstruction and cloacal dilatation, phenocopying human congenital LUTO. Collectively, these results support the conclusion that variants in BNC2 are strongly implicated in LUTO etiology as a result of anatomical blockage.
Objective: The DIRAS2 gene is associated with ADHD, but its function is largely unknown. Thus, we aimed to explore the genes and molecular pathways affected by DIRAS2. Method: Using short hairpin RNAs, we downregulated Diras2 in murine hippocampal primary cells. Gene expression was analyzed by microarray and affected pathways were identified. We used quantitative real-time polymerase chain reaction (qPCR) to confirm expression changes and analyzed enrichment of differentially expressed genes in an ADHD GWAS (genome-wide association studies) sample. Results: Diras2 knockdown altered expression of 1,612 genes, which were enriched for biological processes involved in neurodevelopment. Expression changes were confirmed for 33 out of 88 selected genes. These 33 genes showed significant enrichment in ADHD patients in a gene-set-based analysis. Conclusion: Our findings show that Diras2 affects numerous genes and thus molecular pathways that are relevant for neurodevelopmental processes. These findings may further support the hypothesis that DIRAS2 is linked to etiological processes underlying ADHD. (J. of Att. Dis. 2021; 25(4) 572-583).
The microscopic phasespace approach URQMD is used to investigate the stopping power and particle production in heavy systems at SPS and RHIC energies. We find no gap in the baryon rapidity distribution even at RHIC. For CERN energies URQMD shows a pile up of baryons and a supression of multi-nucleon clusters at midrapidity.
Neben dem Erregernachweis beruht die Labordiagnose der Cytomegalie auf der Bestimmung HCMV spezifischer IgG-, IgM- und IgAAntikörper. Von der Industrie werden jedes Jahr neue Antikörpertests basierend auf der ELISA-Technologie angeboten. In der vorliegenden Studie wurden ein neues Testverfahren (Freka CMV-M-ELISA, Fresenius, Bad Homburg) mit bereits seit mehreren Jahren etablierten und zugelassenen ELISAs (Enzygnost CMVIgM; Behringwerke, Marburg und CMV-ELA, Medac, Hamburg) verglichen. Zur Bestimmung der Sensitivität wurden Verlaufsproben von 15 Organtransplantierten mit einer aktiven HCMV-Infektion, welche in den meisten Fällen über ein positives Ergebnis in der HCMV-DNA-PCR und/oder Virusisolierung und/oder quantitative pp65-Antigenbestimmung bestätigt wurde, untersucht. Zur Ermittlung der Spezifität wurde ein Kollektiv von bekannten HCMV-IgM-negativen Serumproben sowie potentiell kreuzreaktive Seren mit Antikörpern gegen andere Herpesviren und Rheumafaktor- bzw. Antinuklear-Antikörper-positive Seren untersucht. Die höchste Sensitivität wurde für den Medac-ELA ermittelt. Der Freka CMV-M ELISA zeigte eine ähnliche Sensitivität und Spezifität wie der Enzygnost CMV-IgM. Relativ zum Erregernachweis über PCR, Virusisolierung und quantitative pp65-Antigenbestimmung dauerte es bei vielen Patienten bis zu mehreren Wochen, ehe eine humorale Immunantwort über die Bildung von spezifischem IgM nachweisbar war. Bei zwei Patienten waren trotz dem Vorliegen einer floriden Cytomegalie keine HCMV-IgM-Antikörper bis zum Ende des Beobachtungszeitraums nachweisbar. Die Ergebnisse unserer Studie zeigen, daß es relativ große Unterschiede in bezug auf die Sensitivität der verschiedenen ELISAs gibt.
A wide variety of enzymatic pathways that produce specialized metabolites in bacteria, fungi and plants are known to be encoded in biosynthetic gene clusters. Information about these clusters, pathways and metabolites is currently dispersed throughout the literature, making it difficult to exploit. To facilitate consistent and systematic deposition and retrieval of data on biosynthetic gene clusters, we propose the Minimum Information about a Biosynthetic Gene cluster (MIBiG) data standard.
Genetic generalised epilepsy (GGE) is the most common form of genetic epilepsy, accounting for 20% of all epilepsies. Genomic copy number variations (CNVs) constitute important genetic risk factors of common GGE syndromes. In our present genome-wide burden analysis, large (≥ 400 kb) and rare (< 1%) autosomal microdeletions with high calling confidence (≥ 200 markers) were assessed by the Affymetrix SNP 6.0 array in European case-control cohorts of 1,366 GGE patients and 5,234 ancestry-matched controls. We aimed to: 1) assess the microdeletion burden in common GGE syndromes, 2) estimate the relative contribution of recurrent microdeletions at genomic rearrangement hotspots and non-recurrent microdeletions, and 3) identify potential candidate genes for GGE. We found a significant excess of microdeletions in 7.3% of GGE patients compared to 4.0% in controls (P = 1.8 x 10-7; OR = 1.9). Recurrent microdeletions at seven known genomic hotspots accounted for 36.9% of all microdeletions identified in the GGE cohort and showed a 7.5-fold increased burden (P = 2.6 x 10-17) relative to controls. Microdeletions affecting either a gene previously implicated in neurodevelopmental disorders (P = 8.0 x 10-18, OR = 4.6) or an evolutionarily conserved brain-expressed gene related to autism spectrum disorder (P = 1.3 x 10-12, OR = 4.1) were significantly enriched in the GGE patients. Microdeletions found only in GGE patients harboured a high proportion of genes previously associated with epilepsy and neuropsychiatric disorders (NRXN1, RBFOX1, PCDH7, KCNA2, EPM2A, RORB, PLCB1). Our results demonstrate that the significantly increased burden of large and rare microdeletions in GGE patients is largely confined to recurrent hotspot microdeletions and microdeletions affecting neurodevelopmental genes, suggesting a strong impact of fundamental neurodevelopmental processes in the pathogenesis of common GGE syndromes.
Background: The human ATP-binding cassette, subfamily B, member 11 (ABCB11) gene encodes the bile salt export pump, which is exclusively expressed at the canalicular membrane of hepatocytes. A frequent variant in the coding region, c.1331 T > C, leading to the amino acid exchange p.V444A, has been associated with altered serum bile salt levels in healthy individuals and predisposes homozygous carriers of the [C] allele for obstetric cholestasis. Recently, elevated bile salt levels were shown to be significantly associated with rates and risk of cirrhosis in patients with chronic hepatitis C virus (HCV) infection treated with pegylated interferon-alpha2 and ribavirin, suggesting a potential role for bile salt levels in HCV treatment outcomes and in the fibrogenic evolution of HCV-related liver disease. The aim of this study was to investigate a possible association of ABCB11 c.1331 T > C with hepatitis C virus (HCV) infection and fibrosis stages as assessed by non-invasive transient elastography in a German cohort of patients.
Methods: ABCB11 c.1331 T > C genotype was determined by allelic discrimination assay in 649 HCV infected cases and 413 controls. Overall, 444 cases were staged for fibrotic progression by measurement of liver stiffness.
Results: Homo- or heterozygous presence of the frequent [C] allele was associated with HCV positivity (OR = 1.41, CI = 1.02 - 1.95, p = 0.037). No association was detectable between the ABCB11 c.1331 T > C genotype and increased liver stiffness.
Conclusions: Our data confirm that homozygous presence of the major [C] allele of ABCB11 c.1331 T > C is a genetic susceptibility factor for HCV infection, but not for liver fibrosis.
The cell—cell signaling gene CDH13 is associated with a wide spectrum of neuropsychiatric disorders, including attention-deficit/hyperactivity disorder (ADHD), autism, and major depression. CDH13 regulates axonal outgrowth and synapse formation, substantiating its relevance for neurodevelopmental processes. Several studies support the influence of CDH13 on personality traits, behavior, and executive functions. However, evidence for functional effects of common gene variation in the CDH13 gene in humans is sparse. Therefore, we tested for association of a functional intronic CDH13 SNP rs2199430 with ADHD in a sample of 998 adult patients and 884 healthy controls. The Big Five personality traits were assessed by the NEO-PI-R questionnaire. Assuming that altered neural correlates of working memory and cognitive response inhibition show genotype-dependent alterations, task performance and electroencephalographic event-related potentials were measured by n-back and continuous performance (Go/NoGo) tasks. The rs2199430 genotype was not associated with adult ADHD on the categorical diagnosis level. However, rs2199430 was significantly associated with agreeableness, with minor G allele homozygotes scoring lower than A allele carriers. Whereas task performance was not affected by genotype, a significant heterosis effect limited to the ADHD group was identified for the n-back task. Heterozygotes (AG) exhibited significantly higher N200 amplitudes during both the 1-back and 2-back condition in the central electrode position Cz. Consequently, the common genetic variation of CDH13 is associated with personality traits and impacts neural processing during working memory tasks. Thus, CDH13 might contribute to symptomatic core dysfunctions of social and cognitive impairment in ADHD.
Preclinical studies point to a pivotal role of the orexin 1 (OX1) receptor in arousal and fear learning and therefore suggest the HCRTR1 gene as a prime candidate in panic disorder (PD) with/without agoraphobia (AG), PD/AG treatment response, and PD/AG-related intermediate phenotypes. Here, a multilevel approach was applied to test the non-synonymous HCRTR1 C/T Ile408Val gene variant (rs2271933) for association with PD/AG in two independent case-control samples (total n = 613 cases, 1839 healthy subjects), as an outcome predictor of a six-weeks exposure-based cognitive behavioral therapy (CBT) in PD/AG patients (n = 189), as well as with respect to agoraphobic cognitions (ACQ) (n = 483 patients, n = 2382 healthy subjects), fMRI alerting network activation in healthy subjects (n = 94), and a behavioral avoidance task in PD/AG pre- and post-CBT (n = 271). The HCRTR1 rs2271933 T allele was associated with PD/AG in both samples independently, and in their meta-analysis (p = 4.2 × 10−7), particularly in the female subsample (p = 9.8 × 10−9). T allele carriers displayed a significantly poorer CBT outcome (e.g., Hamilton anxiety rating scale: p = 7.5 × 10−4). The T allele count was linked to higher ACQ sores in PD/AG and healthy subjects, decreased inferior frontal gyrus and increased locus coeruleus activation in the alerting network. Finally, the T allele count was associated with increased pre-CBT exposure avoidance and autonomic arousal as well as decreased post-CBT improvement. In sum, the present results provide converging evidence for an involvement of HCRTR1 gene variation in the etiology of PD/AG and PD/AG-related traits as well as treatment response to CBT, supporting future therapeutic approaches targeting the orexin-related arousal system.
The highly infectious disease COVID-19 caused by the Betacoronavirus SARS-CoV-2 poses a severe threat to humanity and demands the redirection of scientific efforts and criteria to organized research projects. The international COVID19-NMR consortium seeks to provide such new approaches by gathering scientific expertise worldwide. In particular, making available viral proteins and RNAs will pave the way to understanding the SARS-CoV-2 molecular components in detail. The research in COVID19-NMR and the resources provided through the consortium are fully disclosed to accelerate access and exploitation. NMR investigations of the viral molecular components are designated to provide the essential basis for further work, including macromolecular interaction studies and high-throughput drug screening. Here, we present the extensive catalog of a holistic SARS-CoV-2 protein preparation approach based on the consortium’s collective efforts. We provide protocols for the large-scale production of more than 80% of all SARS-CoV-2 proteins or essential parts of them. Several of the proteins were produced in more than one laboratory, demonstrating the high interoperability between NMR groups worldwide. For the majority of proteins, we can produce isotope-labeled samples of HSQC-grade. Together with several NMR chemical shift assignments made publicly available on covid19-nmr.com, we here provide highly valuable resources for the production of SARS-CoV-2 proteins in isotope-labeled form.